Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of ACTs for Uncomplicated Malaria in Children in Niger
NCT01755559Phase 4Completed
- Sponsor
- Illumina
- Start
- Jun 2013
- Primary completion
- Nov 2014
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate + amodiaquine, dihydroartemisinin + piperaquine, artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by Illumina. Started Jun 2013; status: completed.
02
Drugs
artesunate + amodiaquinedihydroartemisinin + piperaquineartemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01755559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755559.